Thomas J.Meade, PhD
received a B.S. in Chemistry, his M.A. in Biochemistry and his Ph.D. in Inorganic Chemistry. After completing a NIH postdoctoral fellowship at Harvard Medical School, he was a postdoctoral fellow at the California Institute of Technology in the laboratory of Professor Harry B. Gray. In 1991 he joined the Division of Biology and the Beckman Institute at Caltech.
In 2003, he moved to Northwestern University where he is currently the Eileen Foell Chair in Cancer Research and Professor of Chemistry, Biochemistry and Molecular & Cell Biology, Neurobiology & Physiology, and Radiology, as well as the Director of the Center for Advanced Molecular Imaging (CAMI).
Professor Meade's research focuses on bioinorganic coordination chemistry and its application in research that include biological molecular imaging, electron transfer processes and the development of electronic biosensors for the detection of DNA and proteins. He has received numerous awards and founded three biotech companies, Clinical Micro Sensors, PreDx and Ohmx which are developing hand-held devices for protein and DNA detection and bioactivated MR contrast agents for in vivo imaging of cancer.